HYBRID EVENT: You can participate in person at Barcelona, Spain from your home or work.

4th Edition of International Heart Congress

June 22-24,2026 | Hybrid Event

June 22 -24, 2026 | Barcelona, Spain
Heart Congress 2026

Diagnosis and treatment of primary cardiac lymphoma in an immunocompetent 27 year old man

Moataz Taha Mahmoud, Speaker at Cardiovascular Conference
Madinah Cardiac Center, Saudi Arabia
Title : Diagnosis and treatment of primary cardiac lymphoma in an immunocompetent 27 year old man

Abstract:

Background: Primary cardiac lymphomas (PCL) represent extremely rare cardiac tumors which are accompanied by poor prognosis, unless they are timely diagnosed and treated. Despite the rarity of Primary cardiac lymphomas, they should always be kept in mind in the differential diagnosis of cardiac tumors. At the moment the most effective treatment of primary cardiac lymphomas is chemotherapy.

Case presentation: A 27-year-old, immunocompetent man who presented to our hospital due complaining for one week from left inframammary stitching chest pain increase with inspiration, No dyspnea or palpitations. General and cardiac exams were free.
Multi-modality imaging demonstrated a large intracardiac tumor related to the posterior aortic wall and centered on the interatrial septum and protrude through the SVC, which was proven by biopsy, to be a Primary cardiac lymphoma(PCL). The patient received targeted chemotherapy including rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (RCHOP) which led to marked reduction of the tumor size and 18-FDG PET/CT scan showed no evidence of FDG avid metabolically active lesions.
No reported complications related to chemotherapy with no relapse over a 15-month follow-up period.

Conclusions: Cardiac tumors may present by non-specific manifestations. Primary cardiac lymphoma shows a poor prognosis, unless they are treated in the early stages. So, timely diagnosis is imperative. At the moment the most effective treatment is chemotherapy. Keywords: Primary cardiac lymphoma, Imaging, Chemotherapy

Biography:

Moataz Taha Mahmoud is a Lecturer of Cardiology at Cairo University in Egypt and a Senior Registrar of Cardiology at the Madinah Cardiac Center (MCC) in Saudi Arabia. He holds European Board certification in both TTE and TEE and is a Fellow of the American College of Cardiology as well as a Fellow of the Egyptian Society of Cardiology.

Watsapp